N
NextCell Pharma AB
STO:NXTCL
NextCell Pharma AB
STO:NXTCL
Price:
1.284
SEK
0.31%
Market Cap:
kr143m
Cash Flow Statement
Cash Flow Statement
NextCell Pharma AB
NextCell Pharma AB
Currency: SEK
| Nov-2019 | Feb-2020 | May-2020 | Aug-2020 | Nov-2020 | Feb-2021 | May-2021 | Aug-2021 | Nov-2021 | Feb-2022 | May-2022 | Aug-2022 | Nov-2022 | Feb-2023 | May-2023 | Aug-2023 | Nov-2023 | Feb-2024 | May-2024 | Aug-2024 | Nov-2024 | Feb-2025 | May-2025 | Aug-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||||||
| Net Income |
(22)
|
(17)
|
(17)
|
(18)
|
(19)
|
(23)
|
(25)
|
(25)
|
(26)
|
(28)
|
(31)
|
(35)
|
(38)
|
(39)
|
(41)
|
(41)
|
(42)
|
(41)
|
(39)
|
(43)
|
(41)
|
(39)
|
(41)
|
(36)
|
|
| Depreciation & Amortization |
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
3
|
3
|
|
| Other Non-Cash Items |
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(2)
|
(0)
|
(0)
|
(2)
|
(1)
|
0
|
(1)
|
(1)
|
(1)
|
(6)
|
(7)
|
1
|
1
|
6
|
7
|
(3)
|
(4)
|
(5)
|
(4)
|
4
|
(0)
|
0
|
2
|
(5)
|
|
| Cash from Operating Activities |
(23)
N/A
|
(17)
+27%
|
(16)
+2%
|
(19)
-15%
|
(20)
-4%
|
(23)
-15%
|
(25)
-11%
|
(26)
-2%
|
(26)
-3%
|
(33)
-25%
|
(37)
-12%
|
(33)
+10%
|
(36)
-8%
|
(32)
+11%
|
(33)
-4%
|
(44)
-32%
|
(45)
-4%
|
(46)
0%
|
(43)
+5%
|
(38)
+12%
|
(41)
-8%
|
(37)
+9%
|
(36)
+3%
|
(39)
-8%
|
|
| Investing Cash Flow | |||||||||||||||||||||||||
| Capital Expenditures |
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
(6)
|
(6)
|
(7)
|
(7)
|
(9)
|
(10)
|
(9)
|
(11)
|
(4)
|
(4)
|
(3)
|
(0)
|
(0)
|
(0)
|
(2)
|
(2)
|
(4)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Cash from Investing Activities |
(0)
N/A
|
(1)
-80%
|
(1)
-46%
|
(1)
+53%
|
(1)
+8%
|
(0)
+86%
|
(0)
-473%
|
(6)
-1 207%
|
(6)
+1%
|
(7)
-23%
|
(7)
+5%
|
(9)
-38%
|
(10)
-7%
|
(9)
+7%
|
(12)
-24%
|
(4)
+64%
|
(4)
+15%
|
(3)
+26%
|
(0)
+86%
|
(0)
+77%
|
(0)
+46%
|
(2)
-3 405%
|
(3)
-59%
|
(4)
-69%
|
|
| Financing Cash Flow | |||||||||||||||||||||||||
| Net Issuance of Common Stock |
36
|
21
|
21
|
21
|
21
|
176
|
186
|
165
|
0
|
10
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
40
|
40
|
40
|
40
|
37
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
0
|
0
|
(0)
|
0
|
0
|
(15)
|
(16)
|
(16)
|
0
|
(1)
|
(0)
|
1
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
(5)
|
(6)
|
(6)
|
(6)
|
(2)
|
|
| Cash from Financing Activities |
36
N/A
|
22
-40%
|
21
-2%
|
21
+1%
|
21
0%
|
161
+653%
|
171
+6%
|
149
-13%
|
149
+0%
|
9
-94%
|
0
-100%
|
1
+3 242%
|
1
+14%
|
1
+6%
|
1
+11%
|
1
+3%
|
1
+28%
|
1
-1%
|
1
-12%
|
35
+3 639%
|
34
-1%
|
34
+0%
|
34
+0%
|
35
+2%
|
|
| Change in Cash | |||||||||||||||||||||||||
| Net Change in Cash |
13
N/A
|
4
-70%
|
3
-12%
|
2
-46%
|
1
-40%
|
138
+12 527%
|
145
+5%
|
117
-19%
|
117
0%
|
(31)
N/A
|
(44)
-42%
|
(42)
+4%
|
(45)
-8%
|
(41)
+10%
|
(44)
-8%
|
(47)
-7%
|
(48)
-2%
|
(47)
+2%
|
(43)
+10%
|
(3)
+92%
|
(6)
-95%
|
(4)
+33%
|
(4)
+7%
|
(8)
-106%
|
|
| Free Cash Flow | |||||||||||||||||||||||||
| Free Cash Flow |
(24)
N/A
|
(18)
+25%
|
(18)
0%
|
(20)
-12%
|
(21)
-4%
|
(23)
-12%
|
(26)
-13%
|
(31)
-21%
|
(32)
-2%
|
(40)
-25%
|
(44)
-9%
|
(43)
+3%
|
(46)
-8%
|
(41)
+10%
|
(45)
-8%
|
(48)
-8%
|
(49)
-2%
|
(48)
+2%
|
(44)
+10%
|
(38)
+13%
|
(41)
-7%
|
(39)
+5%
|
(38)
+1%
|
(43)
-12%
|
|
Switch to:
Switch to:
See Also
Discover More
